Houston early stage startup accelerator introduces latest cohort

growing gains

The latest cohort from gBETA Houston has been announced and is currently underway at the Downtown Launchpad. Photo courtesy of Downtown Launchpad

Five Houston startups are joining a global accelerator for a seven-week program to strategically grow their businesses.

Houston's gBETA, a part of gener8tor in partnership with the Downtown Launchpad, has launched its spring cohort — the seventh cohort since its launch in Houston in 2019 — this month. The free program lasts seven weeks and connects companies to gener8tor's network of mentors, customers, corporate partners, and investors.

“We’re thrilled to partner with Downtown Launchpad to bring these programs to life and bolster the technology and sustainability industries in Houston,” says Lauren Usher, gener8tor gBETA vice president, in a news release.

gBETA's equity-free model provides coaching for its cohort companies, which are all Houston-based, home-grown.

“It’s exciting to see the seventh cohort of gBETA Houston come together. We’ve seen so much growth from our previous alumni from our program, and we’re excited for that same impact to flourish with this incoming cohort,” says Muriel Foster, gBETA Houston director, in the release.

The ongoing cohort's members include:

  • Adaptagym revolutionizes the fitness and rehabilitation industries by offering a comprehensive and user-friendly platform that caters to the unique needs of all persons on the ability spectrum. The company matches users with the appropriate fitness and allied health professionals. Adaptagym is currently partnering with one clinic and four individuals for beta testing.
  • Circle.ooo is a B2B2C technology company streamlining event tech for small-to-medium event hosts, attendees and sponsors. The app-within-app concept allows event holders to create a free ‘Circle’, and Attendees create a single 'universal profile' digicard to instantly register for any Event without having multiple accounts, profiles or inputting data fields. Circle is a Houston-based Delaware C-Corp, is currently testing v 2.0 of the app, and has 27 customers on their waitlist.
  • Financial Aid Frenzy transforms the way students pay for college, one dollar at a time. Financial Aid Frenzy's crowdfunding platform is tailored to assist students in getting the money needed for their education by connecting them with donors who are passionate about helping them achieve their educational fundraising goals. Financial Aid Frenzy is a Houston-based Delaware C-Corp, with 40 customers interested in the platform.
  • Kash-In Academy utilizes digital “kash” to increase student engagement through monetized lessons and quizzes. With the Kash-In Academy platform, teachers are able to deposit “kash” for positive behavior and academic achievement. Kash-In Academy is approved in 12 school districts servicing 932 teachers and 8,069 students.
  • MendIt’s apparel care marketplace amplifies the choices for consumers to manage their closets more sustainably and empowers retailers with aftercare solutions that elevate their brand. Retailers work with MendIt to offer long-term product care to customers, helping to extend the life of their clothing, save money through reduced returns, and direct capital to local businesses. MendIt’s product is live and available nationwide via shipping, with three local drop-off locations in the Houston market, a waiting list of “menders” across 9 states, and hundreds of garments mended to date.
From Your Site Articles
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."

NASA taps Houston-area company to explore low-cost spacecraft delivery

Webster-based Arrow Science and Technology is one of six companies picked by NASA to study low-cost ways to launch and deliver spacecraft for difficult-to-reach orbits.

In all, nine studies will be performed under a roughly $1.4 million award from NASA. Another Texas company, Cedar Park-based Firefly Aerospace, is also among the six companies working on the studies.

“With the increasing maturity of commercial space delivery capabilities, we’re asking companies to demonstrate how they can meet NASA’s need for multispacecraft and multiorbit delivery to difficult-to-reach orbits beyond current launch service offerings,” Joe Dant, a leader of the Launch Services Program at NASA’s Kennedy Space Center in Florida, said in a news release. “This will increase unique science capability and lower the agency’s overall mission costs.”

Arrow is teaming up with Rockville, Maryland-based Quantum Space for its study. Quantum’s Ranger orbital transfer vehicle provides payload delivery services for spacecraft heading to low-Earth and lunar orbits.

Arrow, a Native American-owned small business, offers technical support and hardware manufacturing services for the space and defense industries.

James Baker, founder and president of Arrow, said in a news release that the combination of his company’s deployment systems with Quantum’s Ranger vehicle “allows our customers the ability to focus on the development of their payload[s] while we take care of getting them where they need to be.”

“This is an exciting opportunity to demonstrate the unique capabilities of our highly maneuverable Ranger spacecraft, which will expand NASA’s options for reaching dynamic and challenging … orbits,” Kerry Wisnosky, CEO of Quantum Space, added in the release.

The nine studies are scheduled to be completed by mid-September.

NASA said it will use the studies’ findings “to inform mission design, planning, and commercial launch acquisition strategies for risk-tolerant payloads, with a possibility of expanding delivery services to larger-sized payloads and to less risk-tolerant missions in the future.”

ExxonMobil may pause plans for $7 billion Baytown hydrogen plant

Change of Plans

Spring-based ExxonMobil, the country’s largest oil and gas company, might delay or cancel what would be the world’s largest low-carbon hydrogen plant due to a significant change in federal law. The project carries a $7 billion price tag.

The Biden-era Inflation Reduction Act created a new 10-year incentive, the 45V tax credit, for production of clean hydrogen. But under President Trump’s "One Big Beautiful Bill Act," the window for starting construction of low-carbon hydrogen projects that qualify for the tax credit has narrowed. The Inflation Reduction Act mandated that construction start by 2033. But the Big Beautiful Bill switched the construction start time to early 2028.

“While our project can meet this timeline, we’re concerned about the development of a broader market, which is critical to transition from government incentives,” ExxonMobil Chairman and CEO Darren Woods said during the company’s recent second-quarter earnings call.

Woods said ExxonMobil is working to determine whether a combination of the 45Q tax credit for carbon capture projects and the revised 45V tax credit will help pave the way for a “broader” low-carbon hydrogen market.

“If we can’t see an eventual path to a market-driven business, we won’t move forward with the [Baytown] project,” Woods said.

“We knew that helping to establish a brand-new product and a brand-new market initially driven by government policy would not be easy or advance in a straight line,” he added.

Woods said ExxonMobil is trying to nail down sales contracts connected to the project, including exports of ammonia to Asia and Europe and sales of hydrogen in the U.S.

ExxonMobil announced in 2022 that it would build the low-carbon hydrogen plant at its refining and petrochemical complex in Baytown. The company has said the plant is slated to go online in 2027 and 2028.

As it stands now, ExxonMobil wants the Baytown plant to produce up to 1 billion cubic feet of hydrogen per day made from natural gas, and capture and store more than 98 percent of the associated carbon dioxide. The company has said the project could store as much as 10 million metric tons of CO2 per year.

---

This article originally appeared on EnergyCapitalHTX.com.

View All Listings